Abstract

Background. Neisseria gonorrhoeae, a sexually transmitted infection, is associated with adverse pregnancy and neonatal outcomes. Emerging resistance towards various antibiotics has been observed globally. However, there is a lack of data on antimicrobial susceptibility patterns in N. gonorrhoeae isolated from pregnant women in our setting. This study fills in this gap in the literature. Methods. The study population included pregnant women, recruited from the antenatal clinic of the King Edward VIII hospital (KEH) in Durban. Endocervical swabs were obtained from 307 women. The swab was placed in Amies Charcoal media for culture assessments. Pure isolates of N. gonorrhoeae were subjected to antimicrobial susceptibility testing using the Etest™ method. The MIC values were assessed in accordance with the European Committee on Antimicrobial Susceptibility Testing (EUCAST, 2019) breakpoints. Results. The prevalence of N. gonorrhoeae by culture was 1.9%. High MIC values to penicillin G (12-64 mg/L) indicating a resistant phenotype were observed for all isolates tested, with 50% of the isolates displaying complete resistance. Isolates with intermediate (1 mg/L) and resistance (1.9-32 mg/L) profiles to tetracycline were observed. Resistance to ciprofloxacin (1.16-3 mg/L) was also observed. Isolates displayed either dual or triple resistance to penicillin G, tetracycline, or ciprofloxacin. All isolates showed susceptibility to spectinomycin (>64 mg/L), azithromycin (1 mg/L), ceftriaxone (>0.125 mg/L), and cefixime (>0.125 mg/L). Conclusion. Despite lack of resistance to ceftriaxone and azithromycin, continuous surveillance for emerging patterns of resistance to these antibiotics is needed since they form part of the treatment guidelines.

Highlights

  • Neisseria gonorrhoeae is the second most prevalent bacterial sexually transmitted infection (STI) and is a major cause of mortality and morbidity [1]

  • A study conducted in South Africa and Zimbabwe reported an overall prevalence of 0.7% for N. gonorrhoeae infections in women from the general population

  • The study population was recruited from the antenatal clinic of the King Edward VIII hospital (KEH) in Durban, South Africa, from November 2018 to July 2019

Read more

Summary

Introduction

Neisseria gonorrhoeae is the second most prevalent bacterial sexually transmitted infection (STI) and is a major cause of mortality and morbidity [1]. A study conducted in South Africa and Zimbabwe reported an overall prevalence of 0.7% for N. gonorrhoeae infections in women from the general population [3]. Other studies conducted in South Africa have reported prevalence rates for N. gonorrhoeae from 3%-11% in women [1, 4, 5]. A study conducted exclusively on pregnant women reported a prevalence of 1.3% for N. gonorrhoeae [6]. There is a lack of data on antimicrobial susceptibility patterns in N. gonorrhoeae isolated from pregnant women in our setting. Pure isolates of N. gonorrhoeae were subjected to antimicrobial susceptibility testing using the EtestTM method. The MIC values were assessed in accordance with the European Committee on Antimicrobial Susceptibility Testing (EUCAST, 2019) breakpoints. Isolates displayed either dual or triple resistance to penicillin G, tetracycline, or ciprofloxacin. Despite lack of resistance to ceftriaxone and azithromycin, continuous surveillance for emerging patterns of resistance to these antibiotics is needed since they form part of the treatment guidelines

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call